NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Terrana Biosciences

Terrana Biosciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.terranabio.com/

Last Round

Seed

Jul 1, 2025

Total Funding Raised

$50M

Company Overview

Terrana Biosciences is an agricultural technology company that develops RNA-based solutions to improve crop resilience, protect against pests and diseases, and enhance plant traits without genetic modification.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

RNA-based agriculturecrop protectionagtechcomputational biologyplant healthRNA therapeuticsmicrobial fermentationbiotech platformgenerative designprecision agriculturenon-GMObiological inputsagri-biotechbio-pesticidessustainable farming

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Terrana Biosciences Comparables

Compare Terrana Biosciences with similar companies based on industry and business-model similarity.

Terrana Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RNAissance Ag
87%
Trillium Ag
86%
Innatrix, Inc.
83%

Terrana Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2025

Key People

Founding team and executive leadership

Ignacio Martinez

Co-Founder, Executive Chairman, Founding CEO

Founding Team

Matt Lingard

Chief Technology Officer

Executive Team

Terrana Biosciences Investors

Notable investors and investment history

Terrana Biosciences investors
InvestorRounds
Flagship PioneeringSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    $50M raised in early funding.

Terrana Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Terrana Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Terrana Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range61
Year Founded2021
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.